Correction: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis.
作者信息
Tokuyasu Daiki, Imai Shungo, Chen Shih-Pin, Ihara Keiko, Watanabe Narumi, Izawa Yoshikane, Nakahara Jin, Hori Satoko, Takizawa Tsubasa
机构信息
Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
出版信息
BMC Neurol. 2025 Jan 28;25(1):40. doi: 10.1186/s12883-025-04052-4.
Abstract
摘要
相似文献
1
Correction: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis.更正：降钙素基因相关肽单克隆抗体治疗偏头痛患者的椎动脉夹层：一例报告及FAERS数据库分析
BMC Neurol. 2025 Jan 28;25(1):40. doi: 10.1186/s12883-025-04052-4.
2
Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis.降钙素基因相关肽单克隆抗体治疗偏头痛患者的椎动脉夹层：一例报告及FAERS数据库分析
BMC Neurol. 2025 Jan 2;25(1):1. doi: 10.1186/s12883-024-04009-z.
3
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.蛋白酶激活受体 2 (PAR2) 单克隆抗体的特征描述和临床前评估，作为偏头痛的预防治疗。
Cephalalgia. 2020 Dec;40(14):1535-1550. doi: 10.1177/0333102420966581. Epub 2020 Nov 1.
4
Patient characteristics and treatment utilization among patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibody and novel acute medication.起始使用自我注射降钙素基因相关肽单克隆抗体和新型急性药物治疗的偏头痛患者的特征和治疗利用情况。
Curr Med Res Opin. 2022 Aug;38(8):1451-1457. doi: 10.1080/03007995.2022.2091333. Epub 2022 Jul 11.
5
Real-world adherence to erenumab, rescue medication utilization, and work absenteeism for patients with migraine: Results from an outcomes-based agreement.偏头痛患者对erenumab的实际依从性、急救药物使用情况及旷工情况：基于结果协议的结果
J Manag Care Spec Pharm. 2025 Mar;31(3):236-244. doi: 10.18553/jmcp.2025.31.3.236.
6
Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?降钙素基因相关肽单克隆抗体能否改善偏头痛和不宁腿综合征？
J Neurol Sci. 2022 Dec 15;443:120462. doi: 10.1016/j.jns.2022.120462. Epub 2022 Oct 20.
7
Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.慢性偏头痛成人的预防性药物治疗：系统评价与经济建模。
Health Technol Assess. 2024 Oct;28(63):1-329. doi: 10.3310/AYWA5297.
8
A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.偏头痛的单克隆抗体疗法和其他预防治疗的综述。
Headache. 2018 May;58 Suppl 1:48-59. doi: 10.1111/head.13302.
9
The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis.降钙素基因相关肽单克隆抗体治疗阵发性偏头痛的疗效和安全性：一项荟萃分析。
Neurol Sci. 2018 Dec;39(12):2097-2106. doi: 10.1007/s10072-018-3547-3. Epub 2018 Sep 4.
10
Switching from ligand to receptor anti-calcitonin gene-related peptide (CGRP) antibodies or vice versa in non-responders: A controlled cohort study.在无反应者中从配体抗降钙素基因相关肽（CGRP）抗体转换为受体抗CGRP抗体或反之：一项对照队列研究。
Eur J Neurol. 2025 Jan;32(1):e16542. doi: 10.1111/ene.16542. Epub 2024 Nov 28.
本文引用的文献
1
Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis.降钙素基因相关肽单克隆抗体治疗偏头痛患者的椎动脉夹层：一例报告及FAERS数据库分析
BMC Neurol. 2025 Jan 2;25(1):1. doi: 10.1186/s12883-024-04009-z.
Zotero 插件